RU2021114352A - USE OF AN ANTIMICROBIAL AGENT BASED ON BETA-GLUCANS FOR THE THERAPY OF CORONAVIRUS INFECTIONS COVID-19 AND MERS - Google Patents
USE OF AN ANTIMICROBIAL AGENT BASED ON BETA-GLUCANS FOR THE THERAPY OF CORONAVIRUS INFECTIONS COVID-19 AND MERS Download PDFInfo
- Publication number
- RU2021114352A RU2021114352A RU2021114352A RU2021114352A RU2021114352A RU 2021114352 A RU2021114352 A RU 2021114352A RU 2021114352 A RU2021114352 A RU 2021114352A RU 2021114352 A RU2021114352 A RU 2021114352A RU 2021114352 A RU2021114352 A RU 2021114352A
- Authority
- RU
- Russia
- Prior art keywords
- beta
- covid
- mers
- antimicrobial agent
- glucans
- Prior art date
Links
- 229920002498 Beta-glucan Polymers 0.000 title claims 5
- 239000004599 antimicrobial Substances 0.000 title claims 4
- 200000000015 coronavirus disease 2019 Diseases 0.000 title claims 4
- 206010053983 Corona virus infection Diseases 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2S,3R,4S,5S,6R)-2-[(2R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 claims 4
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 claims 3
- 206010047461 Viral infection Diseases 0.000 claims 3
- 208000001756 Virus Disease Diseases 0.000 claims 3
- 200000000016 middle east respiratory syndrome Diseases 0.000 claims 3
- 230000000241 respiratory Effects 0.000 claims 3
- 230000017613 viral reproduction Effects 0.000 claims 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 2
- ICIWUVCWSCSTAQ-UHFFFAOYSA-N Iodic acid Chemical compound OI(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-N 0.000 claims 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
Claims (5)
Publications (1)
Publication Number | Publication Date |
---|---|
RU2021114352A true RU2021114352A (en) | 2022-11-21 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023000798A (en) | Functionalized peptides as antiviral agents. | |
WO2021147236A9 (en) | Use of substituted aminopropionate compound in treatment of sars-cov-2 infections | |
ZA202002139B (en) | Combination pharmaceutical agents as rsv inhibitors | |
MX2022010659A (en) | Highly active compounds against covid-19. | |
JP2005511642A5 (en) | ||
EA200800798A1 (en) | PHARMACEUTICAL COMPOSITIONS INTENDED FOR THE TREATMENT OF DISTURBANCES OF THE INTERNAL EAR | |
MX2023001756A (en) | Functionalized peptides as antiviral agents. | |
JP2017078088A5 (en) | ||
JP2017515840A5 (en) | ||
RU2009122281A (en) | MEANS FOR TREATMENT OF DISEASES IN VETERINARIUM ON THE BASIS OF PHOSPHONY SALT | |
RU2010141697A (en) | METHOD FOR OBTAINING SODIUM CARBOXYMETHYL CELLULOSE AND GOSSYPOL COPOLYMER AND ITS APPLICATION IN COMPLEX THERAPY OF PATIENTS WITH AUTISTIC DISORDERS AND COGNITIVE DISORDERS | |
RU2021114352A (en) | USE OF AN ANTIMICROBIAL AGENT BASED ON BETA-GLUCANS FOR THE THERAPY OF CORONAVIRUS INFECTIONS COVID-19 AND MERS | |
WO2007062333A3 (en) | New pleuromutilin derivative and its use | |
MX2022011179A (en) | Medical use of daridorexant. | |
WO2021205026A3 (en) | Pharmaceutical composition for treatment of enveloped dna or rna virus induced infections and disorders | |
JP2012526099A5 (en) | ||
EA202191482A1 (en) | OTHER HETEROAROMATIC COMPOUNDS WITH ACTIVITY AGAINST RSV | |
WO2006012146A3 (en) | Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same | |
CA2489208A1 (en) | Interleukin-6 suppressive agent | |
RU2419417C1 (en) | Pharmaceutic composition in form of fluconasole solution, possessing antifungal activity | |
RU2234313C1 (en) | Agent for inactivation of coronaviruses | |
RU2581826C1 (en) | Antiseptic | |
RU2012114097A (en) | THERAPEUTIC AGENT AGAINST CHRONIC PAIN | |
RU2491922C1 (en) | Method for increasing biocidal and therapeutic action of suspension-cream with enrofloxacin | |
FI4037685T3 (en) | Quinoline that modulate serca and its use for treating disease |